Presently, Richard Crowley holds the position of Chief Operating Officer & Executive Vice President for Novavax, Inc.

In the past he was Executive Vice President-Technical Operations at TerSera Therapeutics LLC, Co-President & Chief Operating Officer at Savient Pharmaceuticals, Inc., Director-Biologics Manufacturing at BASF Bioresearch Corp. and Senior Vice President-Biopharmaceutical Operations at ImClone LLC.

Richard Crowley received an undergraduate degree from Denison University and a graduate degree from the University of Pennsylvania.